Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CLVT
CLVT logo

CLVT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.715
Open
2.660
VWAP
2.65
Vol
2.27M
Mkt Cap
1.69B
Low
2.600
Amount
6.01M
EV/EBITDA(TTM)
6.21
Total Shares
640.70M
EV
5.77B
EV/OCF(TTM)
9.18
P/S(TTM)
0.72
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.
Show More

Events Timeline

(ET)
2026-03-10
05:10:00
Clarivate Partners with Claude to Integrate Regulatory Intelligence
select
2026-02-24 (ET)
2026-02-24
16:40:00
Major Averages Bounce Back, Investors Focus on AI News
select
2026-02-24
12:00:00
Major Averages Bounce Back, Investors Focus on AI News
select
2026-02-24
06:20:00
Company Sees FY26 Revenue of $2.3B to $2.42B
select
2026-02-24
06:10:00
Clarivate Reports Q4 Revenue of $617M
select

News

Benzinga
7.5
03-10Benzinga
Clarivate Integrates AI Tools with Claude for Regulatory Intelligence
  • AI Tool Integration: Clarivate's integration of its proprietary regulatory intelligence with Claude's natural language reasoning through the open Model Context Protocol (MCP) allows biopharma and medtech organizations to access authoritative regulatory information directly within their existing AI tools, enhancing decision-making efficiency.
  • Market Performance Analysis: Over the past 12 months, Clarivate's stock has declined by 39.72%, currently trading at $2.63, slightly below the 50-day SMA of $2.66, indicating a bearish long-term trend despite recent gains in after-hours trading.
  • Earnings Expectations: Clarivate is expected to report its next earnings on April 28, 2026, with an EPS estimate of 13 cents (down from 14 cents YoY) and a revenue estimate of $569.31 million (down from $593.70 million YoY), reflecting challenges the company faces.
  • Analyst Rating Dynamics: The stock carries an Underweight rating with an average price target of $4.81, with recent analyst adjustments including Citigroup lowering its target to $2.80 and Barclays to $2.40, indicating cautious market sentiment regarding its future performance.
PRnewswire
7.5
03-10PRnewswire
Clarivate Integrates Regulatory Intelligence into Claude AI Ecosystem
  • Strategic Collaboration: Clarivate's partnership with Claude integrates proprietary regulatory intelligence into AI workflows, enabling biopharma and medtech sectors to access authoritative regulatory data intelligently, thereby enhancing decision-making efficiency and accuracy.
  • Data Integration Innovation: The integration of Cortellis Regulatory Intelligence data via the open Model Context Protocol (MCP) embeds authoritative content directly into customer workflows, combining Claude's natural language understanding with industry-validated sources to provide accurate answers that support faster regulatory decisions.
  • Enhanced Customer Value: The new integration allows regulatory affairs, pharmacovigilance, and life sciences teams to access Clarivate's regulatory intelligence directly, enabling customers to make more informed decisions within their existing AI environments, facilitating the introduction of safer and more effective therapies.
  • Expansion of Intelligent Automation: This integration builds on the recent launch of the CRI AI Assistant, further enhancing anticipatory intelligence and intelligent automation across regulatory workflows, thereby improving customer efficiency in complex decision-making.
Yahoo Finance
7.5
03-10Yahoo Finance
Clarivate Integrates Regulatory Intelligence with Claude AI
  • Strategic Collaboration Upgrade: Clarivate's partnership with Claude integrates proprietary regulatory intelligence into AI workflows, enabling organizations in biopharma and medtech to access authoritative regulatory data more intelligently, thereby enhancing decision-making efficiency.
  • Data Integration Innovation: Through the open Model Context Protocol (MCP), Cortellis Regulatory Intelligence (CRI) data will be embedded into Claude, providing accurate, industry-validated answers that help clients make faster and more confident regulatory decisions.
  • Customer Workflow Optimization: This integration allows Clarivate's regulatory intelligence to work alongside existing AI environments, enabling clients to build intelligent agents that combine CRI with internal data to monitor changes and support decision-making in real-time.
  • Intelligent Automation Expansion: Building on the recent launch of the CRI AI Assistant, this integration further advances anticipatory intelligence and intelligent automation across regulatory workflows, assisting clients in developing safer and more effective therapies.
Benzinga
4.5
03-03Benzinga
Wall Street Plummets Amid Escalating Geopolitical Tensions
  • Oil Price Surge: The escalating conflict between the U.S., Israel, and Iran has driven West Texas Intermediate crude oil prices up by 6.4% to $75.8 per barrel, marking the largest two-day rally since March 2022, indicating heightened market concerns over energy supply disruptions.
  • Market Panic Intensifies: The CBOE Volatility Index surged by 6% to 22.74, reflecting increased investor fear regarding short-term market volatility, with all 11 S&P 500 sectors trading in the red, showcasing widespread market pressure.
  • Fed Policy Expectations Shift: Amid rising inflation fears, the 10-year Treasury yield climbed from 3.97% last Friday to approximately 4.06%, leading traders to reprice expectations for Fed rate cuts, now anticipating fewer chances of cuts in 2026.
  • Strong Dollar Impact: The U.S. dollar index is on track for its largest two-day gain since February 2023, resulting in significant declines in gold and silver prices, with spot gold falling 4.6% to around $5,080 per ounce and silver plummeting 7.8% to $82 per ounce, highlighting the dollar's pressure on commodity markets.
Fool
6.5
03-03Fool
HG Vora Capital Sells All Clarivate Shares in Q4
  • Shareholding Change: HG Vora Capital Management sold all 11,125,000 shares of Clarivate in Q4 2026, resulting in no holdings at quarter-end and a net position change of $42.61 million, indicating a cautious outlook on Clarivate's future prospects.
  • Market Performance: As of Tuesday, Clarivate shares were priced at $2.45, down 42% over the past year, significantly underperforming the S&P 500, which rose about 16% during the same period, reflecting its weak market position.
  • Financial Overview: Clarivate generated $2.46 billion in revenue in 2025, down from $2.56 billion in 2024, although it produced $365.3 million in free cash flow, with recurring revenue now representing 88% of total sales, indicating an improvement in business quality.
  • Strategic Restructuring: Clarivate is actively exploring the sale of its Life Sciences segment to reduce its $4.47 billion debt burden; if recurring revenue growth and deleveraging accelerate, the current depressed price could become attractive, but disappointing divestitures may continue to weigh on returns.
NASDAQ.COM
6.5
03-03NASDAQ.COM
HG Vora Completely Exits Clarivate Shares
  • Position Change: HG Vora sold 11,125,000 shares of Clarivate in Q4, resulting in a $42.61 million decrease in position value, indicating a significant loss of confidence in the company.
  • Financial Performance: Clarivate generated $2.46 billion in revenue for 2025, down from $2.56 billion in 2024, reflecting challenges in its market competitiveness and an ongoing strategic reset.
  • Debt Pressure: Despite a 1.8% increase in annualized contract value, the company's total debt remains at $4.47 billion, suggesting HG Vora's exit may stem from concerns over the firm's future financial health.
  • Market Outlook: With recurring revenue now representing 88% of total sales, if Clarivate can accelerate deleveraging and revenue growth, today's depressed stock price could become attractive; however, disappointing divestitures may continue to weigh on returns.
Wall Street analysts forecast CLVT stock price to rise
5 Analyst Rating
Wall Street analysts forecast CLVT stock price to rise
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 0.000
sliders
Low
3.00
Averages
3.90
High
5.00
Current: 0.000
sliders
Low
3.00
Averages
3.90
High
5.00
Citi
Neutral
downgrade
AI Analysis
2026-03-04
Reason
Citi
Price Target
AI Analysis
2026-03-04
downgrade
Neutral
Reason
Citi lowered the firm's price target on Clarivate to $2.80 from $4.25 and keeps a Neutral rating on the shares.
RBC Capital
Sector Perform
downgrade
$5 -> $3
2026-02-26
Reason
RBC Capital
Price Target
$5 -> $3
2026-02-26
downgrade
Sector Perform
Reason
Yesterday, RBC Capital lowered the firm's price target on Clarivate to $3 from $5 and keeps a Sector Perform rating on the shares. The company delivered solid free cash flow growth and guided to about 10% free cash flow growth at the midpoint in FY26, though the firm's price target reflects the concerns around ongoing AI disintermediation risk, and execution around a potential Life Sciences and Healthcare segment sale, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLVT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Clarivate PLC (CLVT.N) is 4.88, compared to its 5-year average forward P/E of 14.13. For a more detailed relative valuation and DCF analysis to assess Clarivate PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
14.13
Current PE
4.88
Overvalued PE
23.10
Undervalued PE
5.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
12.17
Current EV/EBITDA
6.48
Overvalued EV/EBITDA
17.39
Undervalued EV/EBITDA
6.96

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.09
Current PS
0.89
Overvalued PS
5.47
Undervalued PS
0.72

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

idc. use whatever criteria and methods ne
Intellectia · 11 candidates
Market Cap: 50.00M - 2.00BRegion: USPrice: $0.10 - $5.00Market Cap Category: smallRelative Vol: >= 2List Exchange: XNYS, XNAS, XASESupport Resistance Relationship: PriceBreakResistanceOne Day Rise Prob: >= 60
Ticker
Name
Market Cap$
top bottom
HNST logo
HNST
Honest Company Inc
316.05M
IPSC logo
IPSC
Century Therapeutics Inc
528.16M
GEVO logo
GEVO
Gevo Inc
543.92M
PROK logo
PROK
Prokidney Corp
718.99M
CLVT logo
CLVT
Clarivate PLC
1.67B
VTEX logo
VTEX
VTEX
692.11M
less than 3 usd
Intellectia · 1118 candidates
Price: <= $3.00
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
WIT logo
WIT
Wipro Ltd
27.24B
CIG.C logo
CIG.C
Companhia Energetica De Minas Gerais-CEMIG
7.70B
CIG logo
CIG
Energy of Minas Gerais Co
5.98B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
focus on growth and value
Intellectia · 28 candidates
Market Cap: >= 500.00MPrice: <= $5.00Revenue 5yr Cagr: >= 15Pe Ttm: <= 15
Ticker
Name
Market Cap$
top bottom
NIO logo
NIO
NIO Inc
11.55B
CSAN logo
CSAN
Cosan SA
4.02B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
CLVT logo
CLVT
Clarivate PLC
1.86B
I want to buy penny stock
Intellectia · 182 candidates
Market Cap: <= 2.00BPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
MQ logo
MQ
Marqeta Inc
1.94B
CLVT logo
CLVT
Clarivate PLC
1.86B
NWL logo
NWL
Newell Brands Inc
1.79B
TV logo
TV
Grupo Televisa SAB
1.74B
BITF logo
BITF
Bitfarms Ltd
1.61B
PGEN logo
PGEN
Precigen Inc
1.58B
stocks that went down now
Intellectia · 25 candidates
Beta: HighRiskWeekly Average Turnover: >= 10,000,000Week Price Change Pct: <= $-7.00Month Price Change Pct: <= $-12.00Quarter Price Change Pct: <= $-20.00
Ticker
Name
Market Cap$
top bottom
ORCL logo
ORCL
Oracle Corp
499.58B
INTU logo
INTU
Intuit Inc
146.07B
CEG logo
CEG
Constellation Energy Corp
106.67B
HOOD logo
HOOD
Robinhood Markets Inc
95.24B
NET logo
NET
Cloudflare Inc
59.54B
TEAM logo
TEAM
Atlassian Corp
32.21B
penny stock
Intellectia · 144 candidates
Price: <= $5.00Relative Vol: >= 1Beta: HighRiskWeek Price Change Pct: >= $-15.00
Ticker
Name
Market Cap$
top bottom
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
PLUG logo
PLUG
Plug Power Inc
3.09B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
BB logo
BB
BlackBerry Ltd
2.24B
CLVT logo
CLVT
Clarivate PLC
1.86B
stocks between 2 $ and 3 $
Intellectia · 291 candidates
Price: $2.00 - $3.00
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
WIT logo
WIT
Wipro Ltd
27.24B
CIG.C logo
CIG.C
Companhia Energetica De Minas Gerais-CEMIG
7.70B
CIG logo
CIG
Energy of Minas Gerais Co
5.98B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
Best stock under 3.50 that will 3x
Intellectia · 29 candidates
Market Cap: <= 2.00BPrice: <= $3.50Beta: HighRiskRevenue 5yr Cagr: >= 20Annual Eps Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
CLVT logo
CLVT
Clarivate PLC
1.86B
BITF logo
BITF
Bitfarms Ltd
1.61B
BLND logo
BLND
Blend Labs Inc
732.49M
SNDL logo
SNDL
SNDL Inc
406.85M
LCTX logo
LCTX
Lineage Cell Therapeutics Inc
382.34M
SLQT logo
SLQT
SelectQuote Inc
283.31M

Whales Holding CLVT

L
Leonard Green & Partners, L.P.
Holding
CLVT
+10.58%
3M Return
I
Invenomic Capital Management LP
Holding
CLVT
+5.00%
3M Return
C
Clarkston Capital Partners, LLC
Holding
CLVT
+0.91%
3M Return
B
BW Gestao de Investimentos Ltda.
Holding
CLVT
-1.69%
3M Return
L
Lingotto Investment Management LLP
Holding
CLVT
-5.71%
3M Return
T
Timucuan Asset Management Inc
Holding
CLVT
-7.66%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Clarivate PLC (CLVT) stock price today?

The current price of CLVT is 2.635 USD — it has decreased -0.19

What is Clarivate PLC (CLVT)'s business?

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

What is the price predicton of CLVT Stock?

Wall Street analysts forecast CLVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLVT is3.90 USD with a low forecast of 3.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Clarivate PLC (CLVT)'s revenue for the last quarter?

Clarivate PLC revenue for the last quarter amounts to 617.00M USD, decreased -6.94

What is Clarivate PLC (CLVT)'s earnings per share (EPS) for the last quarter?

Clarivate PLC. EPS for the last quarter amounts to 0.00 USD, decreased -100.00

How many employees does Clarivate PLC (CLVT). have?

Clarivate PLC (CLVT) has 12000 emplpoyees as of March 11 2026.

What is Clarivate PLC (CLVT) market cap?

Today CLVT has the market capitalization of 1.69B USD.